Literature DB >> 3691592

Comparison of concomitant nicardipine hydrochloride and propranolol with propranolol alone in patients with essential hypertension.

J G Nievel1, C W Havard, A P Douglas-Jones.   

Abstract

A twelve-week parallel study was conducted to compare the efficacy and safety of nicardipine plus propranolol with that of propranolol alone in 67 patients with mild to moderate essential hypertension. Efficacy data was analysed for 50 patients. The regimens used were 90 mg X day-1 of nicardipine and 120 mg X day-1 of propranolol. Both treatments significantly reduced supine and standing systolic and diastolic blood pressure from baseline values at all visits. At all visits, concomitant administration of nicardipine and propranolol produced a greater reduction in systolic and diastolic pressures than did propranolol alone, although the difference between treatments did not always reach statistical significance. Few adverse events were reported, and none was clinically important. We conclude that nicardipine taken concomitantly with propranolol is more effective than propranolol alone in treating patients with hypertension and that the combined regimen is well tolerated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3691592     DOI: 10.1007/bf00610374

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Hemodynamic changes associated with long-term antihypertensive therapy with new calcium antagonist.

Authors:  T Fujita; H Noda
Journal:  Jpn Heart J       Date:  1983-07

Review 2.  Calcium antagonists: a new class of drugs.

Authors:  W G Nayler; J D Horowitz
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

3.  The effect of acute and chronic nicardipine therapy on forearm arterial haemodynamics in essential hypertension.

Authors:  J Levenson; A C Simon; J Bouthier; B C Maarek; M E Safar
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

4.  Nicardipine hydrochloride in essential hypertension--a controlled study.

Authors:  J Asplund
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Coronary and systemic hemodynamic effects of nicardipine.

Authors:  C R Lambert; J A Hill; W W Nichols; R L Feldman; C J Pepine
Journal:  Am J Cardiol       Date:  1985-03-01       Impact factor: 2.778

Review 6.  Calcium antagonists. Pharmacodynamic effects and mechanism of action.

Authors:  T T Zsotér; J G Church
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

7.  Antihypertensive effect of nicardipine hydrochloride in essential hypertension.

Authors:  T Takabatake; H Ohta; Y Yamamoto; M Maekawa; S Arai; N Hattori; G Nomura
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-08

8.  Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease.

Authors:  H Pouleur; J Etienne; H Van Mechelen; C Van Eyll; A A Charlier; L A Brasseur; M F Rousseau
Journal:  Postgrad Med J       Date:  1984       Impact factor: 2.401

9.  Blood pressure, heart rate and A-V conduction responses to nicardipine in hypertensive patients receiving atenolol.

Authors:  R Kolloch; K O Stumpe; A Overlack
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 10.  Calcium antagonists.

Authors:  W G Nayler
Journal:  Med J Aust       Date:  1983-11-12       Impact factor: 7.738

View more
  2 in total

1.  Antihypertensive effect of slow-release nicardipine. A placebo-controlled cross-over study.

Authors:  A Salvetti; G Cardellino; M Pesenti; A Caiazza; F Ghisoni; C Del Prato; P F Innocenti; F Ponzanelli; M Errico; M Freda
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.

Authors:  J E Frampton; D Faulds
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.